Individualized HbA1c target selection and achievement in the Multinational Observational Study Assessing Insulin Use (MOSA1c) type 2 diabetes study

2021, 6. Glycemic targets: standards of medical care in diabetes-2021, Diabetes Care, 44, S73, 10.2337/dc21-S006 2017, Standards of medical care in diabetes-2017, Diabetes Care, 40, S1 Garber, 2017, Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 executive summary, Endocr Pract, 23, 207, 10.4158/EP161682.CS Currie, 2010, Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study, Lancet, 375, 481, 10.1016/S0140-6736(09)61969-3 Nicholas, 2013, Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study, PLoS One, 8, 10.1371/journal.pone.0068008 Niswender, 2011, Basal insulin: physiology, pharmacology, and clinical implications, Postgrad Med, 123, 17, 10.3810/pgm.2011.07.2300 Chan, 2009, Multifaceted determinants for achieving glycemic control: the international diabetes management practice study (IDMPS), Diabetes Care, 32, 227, 10.2337/dc08-0435 Holman, 2009, Three-year efficacy of complex insulin regimens in type 2 diabetes, N Engl J Med, 361, 1736, 10.1056/NEJMoa0905479 Jang HC, 2008, When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study, Int J Clin Pract, 62, 1013, 10.1111/j.1742-1241.2008.01792.x Raskin, 2005, Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs, Diabetes Care, 28, 260, 10.2337/diacare.28.2.260 Esposito, 2012, Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients, Diabetes Obes Metab, 14, 228, 10.1111/j.1463-1326.2011.01512.x Kostev, 2015, Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis, Diabetes Metab Syndr Obes, 8, 45, 10.2147/DMSO.S76855 Phillips, 2001, Clinical inertia, Ann Intern Med, 135, 825, 10.7326/0003-4819-135-9-200111060-00012 Ziemer, 2005, Clinical inertia contributes to poor diabetes control in a primary care setting, Diabetes Educ, 31, 564, 10.1177/0145721705279050 Al Mansari, 2018, GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice, BMJ Open Diabetes Res Care, 6, 10.1136/bmjdrc-2018-000519 Strecher, 1995, Goal setting as a strategy for health behavior change, Health Educ Q, 22, 190, 10.1177/109019819502200207 Wolpert, 2001, Metabolic control matters: why is the message lost in the translation? The need for realistic goal-setting in diabetes care, Diabetes Care, 24, 1301, 10.2337/diacare.24.7.1301-a Gerstein, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743 Allen, 2009, Nonadherence, clinical inertia, or therapeutic inertia?, J Manag Care Pharm, 15, 690, 10.18553/jmcp.2009.15.8.690 Blonde, 2017, Gaps and barriers in the control of blood glucose in people with type 2 diabetes, Diab Vasc Dis Res, 14, 172, 10.1177/1479164116679775 Ismail-Beigi, 2011, Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials, Ann Intern Med, 154, 554, 10.7326/0003-4819-154-8-201104190-00007 Ross, 2013, Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes, Am J Med, 126, S38, 10.1016/j.amjmed.2013.06.012 Ross, 2011, Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes, Curr Med Res Opin, 27, 13, 10.1185/03007995.2011.621416 Caballero, 2019, Transcultural diabetes care: a call for addressing the patient as a whole, Endocr Pract, 25, 766, 10.4158/EP-2019-0281 Polinski, 2012, Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study, BMC Endocr Disord, 12, 20, 10.1186/1472-6823-12-20 Polonsky, 2005, Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem, Diabetes Care, 28, 2543, 10.2337/diacare.28.10.2543 Linetzky, 2017, Exploring the role of the patient-physician relationship on insulin adherence and clinical outcomes in type 2 diabetes: insights from the MOSAIc study, J Diabetes, 9, 596, 10.1111/1753-0407.12443 Greenfield, 1995, Development and testing of a new measure of case mix for use in office practice, Med Care, 33, AS47 Napoles, 2009, Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language?, Health Serv Res, 44, 1326, 10.1111/j.1475-6773.2009.00965.x Stewart, 2007, Interpersonal processes of care survey: patient-reported measures for diverse groups, Health Serv Res, 42, 1235, 10.1111/j.1475-6773.2006.00637.x Polonsky, 2005, Assessing psychosocial distress in diabetes: development of the diabetes distress scale, Diabetes Care, 28, 626, 10.2337/diacare.28.3.626 Mauricio, 2017, Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA, Diabetes Obes Metab, 19, 1155, 10.1111/dom.12927 Kunt, 2009, Barriers to insulin initiation and intensification and how to overcome them, Int J Clin Pract Suppl, 164, 6, 10.1111/j.1742-1241.2009.02176.x Tibaldi, 2008, Initiating and intensifying insulin therapy in type 2 diabetes mellitus, Am J Med, 121, S20, 10.1016/j.amjmed.2008.03.023 Ray, 2016, Combination treatment of oral agents and insulin in type 2 diabetes: a narrative review, Int J Diabetes Metabol Disord., 1, 1 Castellana, 2019, Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: a meta-analysis, Sci Rep, 9, 19351, 10.1038/s41598-019-55524-w Sacks, 2016, Hemoglobin A1c and race: should therapeutic targets and diagnostic cutoffs differ among racial Groups?, Clin Chem, 62, 1199, 10.1373/clinchem.2016.255166 Tran, 2019, Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from norwegian general practice, BMC Health Serv Res, 19, 904, 10.1186/s12913-019-4557-4 Mostafa, 2012, Independent effect of ethnicity on glycemia in south asians and white europeans, Diabetes Care, 35, 1746, 10.2337/dc11-2079 Schmieder, 2018, Individualised treatment targets in patients with type-2 diabetes and hypertension, Cardiovasc Diabetol, 17, 18, 10.1186/s12933-018-0661-8 Dalal, 2016, Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets, Diabetes Res Clin Pract, 121, 17, 10.1016/j.diabres.2016.08.004 Khunti, 2018, Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review, Diabetes Obes Metab, 20, 427, 10.1111/dom.13088 Fu, 2016, Treatment intensification for patients with type 2 diabetes and poor glycaemic control, Diabetes Obes Metab., 18, 892, 10.1111/dom.12683